ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Sinus disorder | 22.04.06.002 | 0.000533% | | |
Respiratory tract infection | 22.07.07.001; 11.01.08.017 | - | - | Not Available |
Unevaluable event | 08.01.03.051 | - | - | Not Available |
Hypophagia | 19.09.01.004; 14.03.01.006; 07.01.06.010 | 0.002931% | | Not Available |
Blood count abnormal | 13.01.07.001 | - | - | Not Available |
Osteonecrosis of jaw | 24.04.05.005; 15.02.04.010 | - | - | |
Chronic kidney disease | 20.01.03.017 | - | - | |
Bone marrow failure | 01.03.03.005 | 0.001865% | | |
Thyroid cancer | 16.24.03.001; 05.02.05.001 | 0.000208% | | Not Available |
Pharyngeal disorder | 22.04.05.007 | 0.000533% | | Not Available |
Organising pneumonia | 22.01.02.008 | 0.000278% | | Not Available |
Renal cell carcinoma | 20.01.04.003; 16.08.02.002 | 0.007367% | | Not Available |
Oropharyngeal pain | 22.02.05.022; 07.05.05.004 | 0.005328% | | |
Acute kidney injury | 20.01.03.016 | - | - | |
Posterior reversible encephalopathy syndrome | 17.13.02.007 | 0.005595% | | |
Drug-induced liver injury | 12.03.01.044; 09.01.07.023 | - | - | Not Available |
Hepatic cancer | 09.04.02.008; 16.07.02.004 | 0.000139% | | Not Available |
Pneumocystis jirovecii pneumonia | 11.03.07.005; 22.07.08.009 | 0.000139% | | Not Available |
Candida infection | 11.03.03.021 | 0.001066% | | |
Immune thrombocytopenic purpura | 10.04.01.008; 01.08.01.007 | 0.000533% | | Not Available |
Multiple organ dysfunction syndrome | 08.01.03.057 | - | - | |
Appendicitis perforated | 11.01.07.028; 07.04.06.011 | 0.000799% | | |
Eczema asteatotic | 23.03.04.025 | 0.000533% | | Not Available |
Pneumothorax spontaneous | 22.05.02.007 | 0.000533% | | Not Available |
Renal cancer stage IV | 20.01.04.014; 16.08.02.008 | 0.000139% | | Not Available |
Renal cell carcinoma stage IV | 16.08.02.010; 20.01.04.016 | 0.000139% | | Not Available |
Tumour embolism | 24.01.01.034; 16.32.03.030 | 0.000799% | | Not Available |
Renal cancer metastatic | 20.01.04.012; 16.08.02.006 | 0.001181% | | Not Available |
Pulmonary cavitation | 22.01.02.022 | 0.000533% | | Not Available |
Lymphangiosis carcinomatosa | 24.09.02.007; 16.22.02.009; 01.09.01.027 | 0.000139% | | Not Available |